15. Kaplan JB. Therapeutic potential of biofilm-dispersing enzymes. International Journal of Artificial Organs. 2009;32(9):545–554.

16. Selan L, Berlutti F, Passariello C, Comodi-Ballanti MR, Thaller MC. Serratiopeptidase reduces biofilm formation by Staphylococcus aureus and enhances antibiotic susceptibility. Microbial Pathogenesis. 2015;89:66–72.

17. Olsson B, Johansson M, Gabrielsson J, Bolme P. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. European Journal of Clinical Pharmacology. 1988;34(1):77–82.

18. Posadzki P, Watson LK, Ernst E. Herb–drug interactions: an overview of systematic reviews. British Journal of Clinical Pharmacology. 2013;75(3):603–618.

19. Zhou S, Chan E, Pan SQ, Huang M, Lee EJ. Pharmacokinetic interactions of drugs with St John’s wort. Journal of Psychopharmacology. 2004;18(2):262–276.

20. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. American Journal of Health-System Pharmacy. 2000;57(13):1221–1227.